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ABSTRACT: A synthesis of (+)-gephyrotoxin 287C using (S)-phenylglycinol-derived tricyclic lactam 7 as the starting enantio-
meric scaffold is reported. From the stereochemical standpoint, the key steps are the generation of the DHQ C-5 stereocenter by 
hydrogenation of the C–C double bond, removal of the chiral inductor to give a cis-DHQ, introduction of the DHQ C-2 substituent, 
completion of the (Z)-enyne moiety, and generation of the C-1 stereocenter during closure of the pyrrolidine ring. 
The decahydroquinoline (DHQ) system is present in a wide 
array of complex natural products, which can be classified in 
three main categories according to their isolation source: 
plants (e.g.  Lycopodium species; (–)-cermizine B),1 marine 
organisms (e.g. tunicates and flatworms; lepadins A–H),2 or 
amphibians3 (Figure 1). Among the more than 800 amphibian 
alkaloids isolated so far,4 more than 50 incorporate a simple 
DHQ nucleus (2,5-disubstituted; e.g. in (–)-pumiliotoxin C), 
with only two of these being tricyclic: (–)-gephyrotoxin 287C 
(initially termed HTX-D) and its dihydro derivative                
(–)-gephyrotoxin 289B. The isolation of (–)-gephyrotoxin 
287C in very minor amounts from the skin extracts of the 
Colombian frog Dendrobates histrionicus5 was first reported 
in 1974,6 although its structure was not elucidated until 1977, 




Figure 1. cis-Decahydroquinoline alkaloids. 
Gephyrotoxins are characterized by a cis-DHQ core fused to 
a pyrrolidine ring between the DHQ 2-position and the nitro-
gen atom, and they incorporate a C-1 hydroxyethyl substituent 
and a C-6 cis-enyne or cis-diene five-carbon side chain (pyr-
roloquinoline numbering). The absolute configuration of         
(–)-gephyrotoxins was established as 1S,3aS,5aS,6S,9aR.7,8 
In contrast to other amphibian alkaloids such as pumiliotox-
in C and histrionicotoxins, gephyrotoxin 287C is relatively 
non-toxic, exhibits weak activity as a muscarinic antagonist, 
and acts as a moderate blocker of nicotinic acetylcholine re-
ceptor channels.9  
Although the scarcity of these natural products and their 
neurological profile has stimulated considerable synthetic 
efforts in this area,10 only three enantioselective total syntheses 
of gephyrotoxin 287C have been reported to date.11,12 The first 
one, using L-pyroglutamic acid as the source of chirality, 
generated a controversy about the absolute configuration of 
natural gephyrotoxin 287C, as the synthesized 1S,3aS,5aS, 
6S,9aR enantiomer appeared to be dextrorotatory,11a in contrast 
with the isolated natural product, which had been reported as 
levorotatory.7,8  However, two recent independent enantiose-
lective syntheses unambiguously confirmed that the absolute 
configuration of (–)-gephyrotoxin 287C is 1S,3aS,5aS,6S,9aR 
(X-Ray analysis of the hydrochloride salt),11b and that          
(+)-gephyrotoxin 287C is the 1R enantiomer.11c 
In the context of our studies on the use of tricyclic phenyl-
glycinol-derived oxazoloquinolone lactams as multipurpose 
enantiomeric scaffolds for the synthesis of DHQ-containing 
alkaloids,13 we report herein the synthesis of (+)-gephyrotoxin 
287C. 
Tricyclic lactam A, bearing a functionalized two-carbon 
chain at the DHQ 5-position with the required 4a-H/5-H trans 




fold. This lactam would be accessible by cyclocondensation of 
(S)-phenylglycinol with an appropriate cyclohexenone-derived 
δ-keto ester. After removal of the chiral inductor and activa-
tion of the lactam carbonyl, an α,β-unsaturated pentenoate 
substituent would be stereoselectively (2-H/8a-H trans) in-
stalled at the DHQ 2-position. The introduction of the enyne 
moiety with the required Z stereochemistry and the closure of 
the pyrrolidine ring by an intramolecular conjugate addition 
would assemble the tricyclic pyrroloquinoline system. A final 
reduction of the ester group would complete the synthesis of 
(+)-gephyrotoxin 287C. Scheme 1 outlines our synthetic plan. 
 
Scheme 1. Synthetic Strategy 
 
We initially targeted tricyclic lactam 5, in which the si-
lylethyl substituent would be further elaborated to the pen-
tenynyl chain. The required keto ester 3 was prepared in 94% 
yield by a one-pot procedure from the commercially available 
vinylsilane 2 via a B-alkyl-Suzuki-Miyaura cross-coupling14 
involving a regioselective hydroboration with 9-BBN and a 
subsequent Pd-catalyzed coupling with the known15 bromo 
enone 1 (Scheme 2). However, cyclocondensation of keto 
ester 3 with (S)-phenylglycinol led to the expected lactam 4 in 
low yield, with a significant mass loss after chromatographic 
separation. This result was unexpected because in previous 
work we had successfully used keto esters containing a 
SiMe2Ph moiety in related cyclocondensation reactions.
13b The 
subsequent reduction of the C–C double bond of 4 also proved 
unsatisfactory since the hydrogenation was sluggish and oc-
curred with concomitant reduction of the phenyl rings. 
To circumvent these inconveniences, we decided to manipu-
late the silane moiety prior to the cyclocondensation reaction. 
To this end, silyl derivative 3 was converted to silyl ether 6 by 
Tamao-Fleming oxidation,16 followed by protection of the 
resulting alcohol. In this series, the cyclocondensation reaction 
of 6 with (S)-phenylglycinol and the subsequent catalytic 
hydrogenation of the resulting unsaturated lactam 7 took place 
in satisfactory overall yield (47%) to give tricyclic lactam 8 as 
a single stereoisomer.17 




With our chiral scaffold 8 in hand, the removal of the chiral 
inductor was performed in two steps: alane reduction, which 
brought about both the steroselective reductive cleavage of the 
oxazolidine C–O bond and the reduction of the lactam carbon-
yl, and debenzylation by catalytic hydrogenation in the pres-
ence of Boc2O. A subsequent ruthenium tetroxide promoted
18 
reoxidation of the resulting N-Boc-cis-DHQ 9, which has the 
required absolute configuration at the 4a, 5, and 8a stereocen-
ters, led to bicyclic lactam 10 (Scheme 3). 
Following our synthetic plan, lactam 10 was converted in 
virtually quantitative yield to vinyl triflate 11 using Comins’ 
protocol.19 Then, the stereoselective introduction of a substitu-
ent at C-2 was accomplished by Stille coupling of 11 with 
allyl stannane, followed by reduction of the resulting enecar-
bamate under NaBH3CN-TFA conditions, which provided 
DHQ 12 as a single stereoisomer. A stereoelectronically con-
trolled20 axial attack of the hydride ion from the bottom face of 
the N-acyliminium intermediate B, via a chair-like transition 
state in which the C-8/C-8a bond is axial due to the presence 
of the Boc group, accounts for the observed stereoselectivity. 
Taking advantage of the allyl group present in 12, the pen-
tenoate chain was completed in a three-step sequence involv-
ing the hydroboration-oxidation of the terminal olefin, oxida-
tion of the resulting alcohol 13, and finally, a Wittig olefina-
tion. Unsaturated ester 14 was obtained in six synthetic steps 
and 42% overall yield from lactam 10.21  
The next phase of the synthesis was the completion of the Z-
pentenynyl chain. This was accomplished in good yield and 
complete stereoselectivity by treatment of the aldehyde result-
ing from desilylation-oxidation of 14 with the known bulky 
1,3-disilylpropyne 1622 under Yamamoto’s modified Peterson 






Scheme 3. Stereoselective Introduction of the DHQ C-2 Chain 
 
 
and TMS protecting groups of the resulting enyne 17, a treat-
ment with sodium methoxide, applying previously reported 
conditions,10a,11c brought about the desired aza-Michael cy-
clization, affording tricyclic ester 18. A final treatment with 
DIBALH, and then with NaBH4 to ensure the complete reduc-
tion of the intermediate aldehyde,11b,c gave the target gephy-
rotoxin 287C. Our synthetic gephyrotoxin 287C, of 
1R,3aR,5aR 6R,9aS absolute configuration, showed NMR data 
coincident with those reported for the natural product24 and 
proved to be dextrorotatory {[α]D
 23 = +49.0 (c 0.21, EtOH)}, 
in agreement with the original 1S,3aS,5aS,6S,9aR assignment 
for the natural levorotatory enantiomer.7  
Our synthesis of (+)-gephyrotoxin 287C illustrates the po-
tential of phenylglycinol-derived tricyclic oxazoloquinolone 
lactams as multipurpose scaffolds for the enantioselective 
assembly of DHQ-containing alkaloids. After the stereoselec-
tive generation of the tricyclic lactam scaffold 7, the synthesis 
is based on a series of stereoselective transformations, namely 
generation of the DHQ C-5 stereocenter by catalytic hydro-
genation of the C–C double bond, reductive cleavage of the 
oxazolidine ring to give a cis-DHQ, generation of the DHQ C-
2 stereocenter with stepwise introduction of the pentenoate 
chain, completion of the (Z)-enyne moiety, and generation of 
the C-1 stereocenter during the closure of the pyrrolidine ring. 
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